Immune IQ

Immune IQ is a private, early-stage diagnostics company leveraging artificial intelligence to decode the human immune system. Its core focus is on creating a platform that profiles immune status to enable personalized health monitoring, disease risk assessment, and potentially guide therapeutic decisions. Operating in a high-growth segment at the intersection of AI, immunology, and digital health, the company is likely pre-revenue and in a technology development phase. Its success hinges on validating its platform, securing strategic partnerships, and navigating a competitive landscape of multi-omics and wellness diagnostics.

AI-driven platform for comprehensive immune system profiling, integrating high-dimensional immunological data (e.g., cell populations, antibody repertoires) with machine learning algorithms to generate personalized health insights.

Immune IQ competes in a crowded field including direct-to-consumer wellness profiling companies (e.g., InsideTracker), specialized immunology CROs, large diagnostic firms developing companion diagnostics, and other AI-driven multi-omics platforms (e.g., Freenome, Tempus in oncology). Differentiation requires superior predictive power and clear clinical utility.